-

PanTheryx Welcomes Wilderness Medicine Practitioner Stuart Harris to its Board of Directors

Dr. Harris Joins PanTheryx’s Board to Help Advance Digestive and Immune Health Research and Consumer Awareness

PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the addition of N. Stuart Harris, M.D. to its Board of Directors. Dr. Harris, is chief of the Massachusetts General Hospital (MGH) Division of Wilderness Medicine, which is the practice of resource limited medicine under austere conditions. As a PanTheryx board member, Dr. Harris will collaborate with the company’s leadership team and its scientific advisory board to advance research focused on probiotics and cow colostrum for digestive and immune health.

“We are pleased to welcome Dr. Harris to PanTheryx’s board of directors as he brings a unique perspective to preventative health and wellness,” said David Abramson, executive chairman of the board of directors, PanTheryx. “Dr. Harris’ clinical and field research as well has his extensive experience working with diverse populations will give PanTheryx new insights as we create high-quality health and wellness products that target digestive and immune health.”

Dr. Harris brings more than twenty years of experience in emergency medicine, clinical research, and the interplay between the environment and human health. Dr. Harris is a full-time attending physician in the MGH Emergency Department, an Associate Professor of Emergency Medicine at Harvard Medical School, and an affiliated faculty member at the Arctic Initiative at the Belfer Center, Harvard Kennedy School of Government.

Dr. Harris graduated from the Harvard Affiliated Emergency Medicine Residency in 2003. His research focuses on investigating the pathogenesis and treatment of high-altitude illness and on the relationship between climate change and human health. His research teams are active on/in the Himalayas, Mt. Kilimanjaro, the Andes, Alaska, and far Eastern Siberia and have been funded by the National Institutes of Health, the U.S. DOD, MGH, and HMS.

“As a wilderness medicine expert and emergency physician, I’ve experienced the power of proper nutrition to keep all of the body’s systems operating at optimal capacity by supporting the microbiome,” commented Dr. Stuart Harris. “I’m excited to be member of PanTheryx’s board of directors to help impact clinical nutrition research and underscore how the digestive system is critical to health and wellness.”

To learn more about PanTheryx, please visit www.pantheryx.com.

About PanTheryx

PanTheryx™ is a nutrition and biotechnology company committed to the global commercialization of health and wellness solutions for the human and animal health markets. From leading cutting-edge research, to supplying best-in-class ingredients, to commercializing category-leading consumer brands, PanTheryx is dedicated to delivering revolutionary approaches for digestive, immune, and microbiome health. As the world’s largest producer of colostrum, PanTheryx provides its proprietary ColostrumOne™ and La Belle® Colostrum ingredients to its partners serving the global human and animal health markets. In addition to the products it develops with its partners, the PanTheryx portfolio of consumer brands include TruBiotics®, Goodgut®, Life’s First Naturals™ and DiaResQ®. To learn more about PanTheryx, its consumer brands, and colostrum ingredients, please visit www.pantheryx.com.

Contacts

Andrea Martin
Andrea D. Martin Consulting LLC for PanTheryx
P: 443.927.6183
E: andrea@consultmartin.com

PanTheryx


Release Versions

Contacts

Andrea Martin
Andrea D. Martin Consulting LLC for PanTheryx
P: 443.927.6183
E: andrea@consultmartin.com

More News From PanTheryx

New All-Natural Digestive Relief for GLP-1 Users: Introducing Relesium™

BOULDER, Colo.--(BUSINESS WIRE)--Starting today, Relesium™, a new gut-health solution for GLP-1 users, is available as an all-natural dietary supplement designed to alleviate occasional gastrointestinal (GI) issues and support gut health. With its patented formula, Relesium offers a targeted, safe, and clinically backed solution for individuals experiencing occasional digestive side effects, such as nausea, diarrhea, constipation, and bloating, from GLP-1 weight-loss medications such as Ozempic...

A New Branded Patented Formulation Shown to Alleviate GLP-1 Medication-Induced Gut Issues

BOULDER, Colo.--(BUSINESS WIRE)--PanTheryx®, a global nutrition and biotechnology company, today announced the launch of Relesium™, a patented, all-natural supplement formulated to address pervasive gut-related side effects of glucagon-like peptide 1 (GLP-1) medications, including popular weight-loss drugs like Ozempic®, Wegovy®, Mounjaro® and other Semaglutides and Tirzepatides. Relesium combines the scientifically backed benefits of chicken egg powder and bovine colostrum, offering an all-nat...

TruBiotics® Increases Walmart Distribution as Consumer Digestive and Immune Health Needs Surge

BOULDER, Colo.--(BUSINESS WIRE)--Today, PanTheryx®, a global leader in digestive and immune health products, announces the expansion of its TruBiotics® Adult Capsules to more than 2,200 Walmart stores, making it easier to find the leading probiotic nationwide. Coinciding with this expansion, DiaResQ® Toddler’s, a sister brand to TruBiotics, launches in 1,000 Walmart stores across the country. Both brands, known for their affordability and quality, are delivering on their promise to provide scie...
Back to Newsroom